SpaceX nears $150 first-day price as lockups test $2 trillion valuation

  • SpaceX shares rose to $147.95, up 18% over 30 days and above the $135 IPO price.
  • Analysts set a $216 median 12-month target, implying 46% upside from September 4.
  • SpaceX reported $7.81 billion in second-quarter revenue and a $541 million net deficit.

SpaceX closed at $147.95 on September 4, up 18% over 30 days and above its $135 IPO price, as the shares approached their $150 first-day trading level and attempted to reclaim a $2 trillion valuation, approximately 2,702 trillion won. The stock previously fell as low as $104.83 during its brief public trading period; an earlier report placed the post-earnings low at $108.27. Among 41 analysts, the median 12-month target is $216, implying 46% upside, while the mean target is $221.20 and the consensus recommendation is Moderate Buy. Estimates range from $75 to $800. SpaceX reported second-quarter revenue of $7.81 billion, up 91.9% year over year, while EPS of negative $0.09 beat the consensus loss estimate by $0.17. The company remained unprofitable, recording a $541 million net deficit compared with $1 billion a year earlier. Quarterly spending totaled $18.4 billion, including $15.8 billion for AI infrastructure. Bond Capital Management established a $180.6 million position representing 59.2% of its portfolio, while other firms also initiated holdings. SpaceX has computing agreements with Alphabet and Anthropic that are projected to generate $26 billion in annual revenue, and it plans to deploy more than 1 million satellites as orbital data centers beginning in 2028. The stock remains exposed to phased lockup releases involving 4.6 billion employee and early-investor shares. The latest update identifies September 9 as a key unlock date, while earlier scheduling details cited September 10 and September 25 releases, followed by additional unlocks after third-quarter earnings in November and into early December. Investors are also watching a possible mid-September Starship Test 14 launch, while analysts remain divided over capital intensity, unproven technologies and potential selling pressure.

The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.